Tykerb 250mg Tablet

Prezentare produs

About Tykerb

Tykerb is a medication containing the active ingredient Lapatinib, classified as Cancer medication. Lapatinib (INN), used in the form of lapatinib ditosylate (USAN) is an orally active drug for breast cancer and other solid tumours. It is a dual tyrosine kinase inhibitor which interrupts the HER2/neu and epidermal growth factor receptor (EGFR) pathways.

Key Benefits & Uses

• Used for: 1 INDICATIONS AND USAGE Lapatinib tablets are indicated in combination with: capecitabine for the treatment of patients with advanced or metastatic.
• Use only as directed on the product label or by a healthcare professional.
• Follow the authorised product information for dosing and duration of use.

Active Ingredient & Action

Lapatinib, the active ingredient in Tykerb, belongs to the Cancer medication class. 1 INDICATIONS AND USAGE Lapatinib tablets are indicated in combination with: capecitabine for the treatment of patients with advanced or metastatic breast cancer whose tumors overexpress human epidermal growth factor receptor 2 (HER2) and who have received prior therapy, including an anthracycline, a taxane, and. Inactive ingredients: not listed in source data.

Important Notes

Always read and follow the label instructions carefully before taking Tykerb. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use Tykerb for extended periods without medical advice.